Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China · Delayed Price · Currency is CNY 306.67
-6.33 (-2.02%)
Last updated: Aug 20, 2025
SHA:688506 Market Cap
SHA:688506 has a market cap or net worth of 130.31 billion as of August 22, 2025. Its market cap has increased by 100.94% in one year.
Market Cap
130.31B
Enterprise Value
127.92B
Revenue
441.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
306.67
Market Cap Chart
Since January 6, 2023, SHA:688506's market cap has increased from 12.85B to 130.31B, an increase of 913.92%. That is a compound annual growth rate of 141.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 130.31B | 69.49% |
| Dec 31, 2024 | 76.88B | 37.05% |
| Dec 29, 2023 | 56.10B | 336.51% |
| Jan 6, 2023 | 12.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 412.02B |
| Shenzhen Mindray Bio-Medical Electronics | 283.22B |
| WuXi AppTec | 265.02B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.20B |
| Aier Eye Hospital Group | 121.59B |
| Shanghai United Imaging Healthcare | 106.23B |
| Yunnan Baiyao Group Co.,Ltd | 100.86B |
| Huadong Medicine | 80.37B |